GE HealthCare Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GEHC research report →
About the company
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients.
- CEO
- Peter J. Arduini
- IPO
- 2022
- Employees
- 53,000
- HQ
- Chicago, IL, US
Price Chart
- Market Cap
- $29.60B
- P/E
- 19.71
- P/S
- 1.48
- P/B
- 2.78
- EV/EBITDA
- 11.16
- Div Yield
- 0.22%
- Gross Margin
- 42.55%
- Op Margin
- 12.46%
- Net Margin
- 7.54%
- ROE
- 14.77%
- ROIC
- 6.71%
- Revenue
- $20.63B · 4.84%
- Net Income
- $2.08B · 4.57%
- EPS
- $4.56 · 4.35%
- Op Income
- $2.76B
- FCF YoY
- -2.84%
- 52W High
- $89.77
- 52W Low
- $58.75
- 50D MA
- $66.07
- 200D MA
- $74.86
- Beta
- 0.86
- Avg Volume
- 4.82M
Get TickerSpark's AI analysis on GEHC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 26 | Lobo Kevin | buy | 10,000 |
| May 15, 26 | Rackliffe Philip | other | 16,458 |
| May 15, 26 | Bankes Jeannette | other | 5,535 |
| May 12, 26 | Hochman Rodney F | buy | 1,618 |
| May 8, 26 | Yang Watkin Phoebe L. | buy | 1,000 |
| May 7, 26 | Yang Watkin Phoebe L. | other | 3,586 |
| May 7, 26 | CULP H LAWRENCE JR | other | 4,157 |
| May 7, 26 | CULP H LAWRENCE JR | other | 3,586 |
| May 7, 26 | Hochman Rodney F | other | 2,689 |
| May 7, 26 | Hochman Rodney F | other | 3,586 |
Our GEHC coverage
Recent articles, reports, and earnings notes.
GE HealthCare (GEHC): Backlog and PDx Growth vs. Margin Pressure
GE HealthCare offers a balanced medtech setup with a $21.8B backlog, growing pharmaceutical diagnostics, and solid free cash flow, but tariffs and margin pressure are still weighing on results.
GE HealthCare Technologies Inc. (GEHC) falls on deep earnings analysis
GE HealthCare Technologies Inc. (GEHC) falls after a closer look at earnings shows a profit miss, margin pressure, and a lowered full-year outlook despite solid revenue and backlog growth. This deep-dive analysis breaks down segment performance, inflation headwinds, and why investors focused on guidance rather than sales.
GE HealthCare Technologies Inc. (GEHC) falls 14% on Q1 miss
GE HealthCare Technologies Inc. (GEHC) falls sharply after its first-quarter report missed profit estimates and management cut full-year guidance. Revenue beat expectations, but inflationary cost pressure and weaker profit outlook overshadowed the top-line strength, triggering heavy selling on above-average volume.
Want a deeper read on GEHC?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.